What to Expect in a Clinical Trial: A Guide for Participants

Deciding whether to participate in a clinical trial is a significant personal decision — one that deserves clear, honest information rather than either promotional enthusiasm or unnecessary alarm. This guide explains what the experience of clinical trial participation actually involves, from the screening process through completion, including the rights and protections you have as a participant that the research team is legally and ethically obligated to uphold.

Before You Consider Enrolling: What Clinical Trials Are and Aren't

Clinical trials test whether new treatments, devices, or interventions are safe and effective, or whether established treatments work better in new combinations, doses, or patient populations. They are not experimental procedures conducted outside mainstream medicine. They are carefully designed, rigorously reviewed studies that must be approved by an Institutional Review Board (IRB) before the first participant is enrolled, and monitored by the study sponsor throughout.

Participation in a clinical trial is not a last resort and it is not a gamble. For some conditions, a clinical trial may offer access to a treatment that is otherwise unavailable. For others, it may offer the most thoroughly monitored medical care you will receive. For still others, particularly healthy volunteers in Phase I studies: it is a contribution to medical knowledge with only modest personal medical benefit and some defined degree of risk. Understanding which kind of trial you are being offered, and what the honest expected benefit-to-risk balance is, is the foundation of an informed decision.

The Screening Process

Before you can enroll in a clinical trial, you must go through a screening process designed to determine whether you meet the study's eligibility criteria. Eligibility criteria, called inclusion and exclusion criteria, exist to protect participants (by excluding people for whom the study drug might be unsafe) and to ensure the study generates interpretable data (by enrolling a population that reflects the group the drug is intended for).

Screening typically involves a medical history review, a physical examination, laboratory tests, and sometimes imaging or other diagnostic procedures. Some of these may be covered by the study; others may not be, depending on the study and your insurance. Ask the research team specifically which procedures are covered by the study and which may be billed to your insurance before you begin screening.

Not everyone who is screened will be eligible to enroll. If you are found to be ineligible, the research team should explain why, and should follow up with you about whether there is any impact on your regular care for any finding identified during screening.

The Consent Process: Your Most Important Protection

Before you undergo any study-specific procedure, including screening. You must be given the opportunity to review and sign an informed consent form. The consent form is a legal document that describes the study in plain language: its purpose, what procedures you will undergo, the foreseeable risks and potential benefits, what alternatives exist, how your privacy will be protected, and how to contact the research team if you have questions or concerns.

The consent conversation should never feel rushed. Federal regulations (21 CFR Part 50) require that consent be obtained under circumstances that provide sufficient opportunity to consider whether to participate and that minimize the possibility of coercion or undue influence. You should be encouraged to take the form home, read it carefully, and discuss it with family members or your regular physician before making a decision. There is no ethical timeframe within which you are expected to decide.

You will be asked to sign and date the consent form, and the person who explained the study to you will also sign. You should receive a copy of the signed form to keep. If the study continues for an extended period and there are any significant changes to the procedures or risks, you will be asked to sign an updated consent form before those changes affect your participation.

Signing the consent form means you have been informed and have chosen to participate. It does not waive any of your legal rights, and it does not release the research team from liability for negligence — this is specifically prohibited by 21 CFR 50.20.

Study Visits: What to Expect During the Trial

Clinical trial visits are more structured and more thorough than a typical clinical appointment. Each visit follows a protocol-specified schedule of procedures, what will be done, in what order, and what documentation is required. The research coordinator (CRC) is typically your primary point of contact and will guide you through the visit procedures.

Common study visit activities include: a review of your health since the last visit (new symptoms, new medications, any hospitalizations or medical events); vital signs measurement; physical examination by the investigator; laboratory blood or urine collection; study drug dispensation and counseling; questionnaires or assessments; and specialized procedures depending on the study (ECGs, imaging, cognitive assessments, etc.).

Visits may be more frequent early in a study, particularly in Phase I or early Phase II, where close safety monitoring is essential, and may decrease in frequency as the study progresses. Some studies require long-term follow-up visits years after the primary study treatment ends. Make sure you understand the full schedule of visits required before enrolling, including how they may affect your work, travel, or other commitments.

The Study Drug or Intervention

If the trial involves an investigational drug, you will typically receive it at study visits rather than through your regular pharmacy. The research team will dispense the drug according to the protocol, provide instructions for taking it (dosing, timing, food interactions, what to avoid), and track what you receive and return. Never adjust your dose or share the drug, the dispensing and accountability process is a regulatory requirement, and any changes to how you are taking the drug must be discussed with the research team and the investigator.

In randomized controlled trials, you may be assigned to a placebo group rather than the active drug group. The consent form will explain whether the trial includes a placebo, what the probability of being assigned to each group is, and whether you or the research team will know your assignment (blinded vs. unblinded design). You have the right to know whether a placebo arm exists, no study can ethically withhold that information from a consenting participant.

Side Effects and Adverse Events

You are expected, and required, to report any new symptoms, medical events, or changes in your health to the research team, whether or not you think they are related to the study drug. The research team will record, evaluate, and if appropriate report these as adverse events. This reporting is not burdensome bureaucracy: it is a core mechanism of the safety monitoring system that protects you and all future participants in the study.

If you experience a serious medical event — hospitalization, a significant new health problem, anything that requires urgent medical attention — contact the research team immediately. Most studies provide a 24-hour contact number for exactly this situation. You should also tell your regular healthcare providers that you are in a clinical trial, and give them the research team's contact information, so that care can be coordinated appropriately.

Your Rights as a Clinical Trial Participant

These rights are not courtesy policies — they are protections established in federal law (21 CFR Part 50, 45 CFR Part 46) and in the international ethical framework for human research established by the Belmont Report and the Declaration of Helsinki. If you feel these rights are being violated, you should contact your study's IRB directly. The IRB contact information must be included in your consent form.

Privacy and Confidentiality

Clinical trial data is confidential — your personal identifying information is protected and separated from the data that is analyzed and submitted to regulatory authorities. In practice, this means your data is typically linked to a participant number rather than your name in research records, and that access to your identifiable information is restricted to authorized study personnel and regulatory authorities (including the FDA, which has the right to inspect records identifying study participants as part of its oversight function — this must be disclosed in your consent form).

Your trial participation is also subject to applicable health privacy laws, including HIPAA in the United States. The consent form's confidentiality section should explain specifically how your data is stored, who has access, and under what circumstances information might be shared. Read this section carefully.

Withdrawing from a Trial

You can withdraw from a clinical trial at any time, for any reason, without penalty. This is a non-negotiable right established in federal regulation. You do not need to explain your reasons, though the research team may ask. You are not required to answer. Your decision to withdraw will not affect your access to standard medical care outside the trial.

When you withdraw, the research team will typically ask whether you consent to have the data collected up to your withdrawal date included in the study analysis. You have the right to refuse this as well — though the research team may explain that including your data helps ensure the analysis is as complete and valid as possible. This is your decision.

Some studies also have circumstances under which the investigator may remove you from the study, for example, if your condition changes in a way that makes continued participation unsafe, or if you develop a condition that the protocol requires excluding. The consent form must disclose these circumstances in advance.

Compensation and Costs

Many clinical trials provide compensation for participant time and inconvenience. This compensation is typically modest — designed to acknowledge the burden of participation without creating a financial incentive so large that it unduly influences the decision to enroll. The specific compensation amounts must be disclosed in the consent form and approved by the IRB.

Study-related costs, the cost of study drug, study-related laboratory tests, and study-specific procedures — are typically covered by the sponsor. Costs associated with your standard of care medical treatment during the study may or may not be covered. This varies by study and by your insurance coverage. Ask the research team explicitly what costs will be covered and what might be billed to your insurance before you agree to enroll.

Questions to Ask Before You Enroll

These questions are not presumptuous. They are exactly what an informed, engaged participant should be asking. A research team that discourages these questions or provides vague answers should raise concern. A team that welcomes them and answers them clearly is demonstrating the kind of transparency that characterizes ethical, well-run research.

Finding Clinical Trials

ClinicalTrials.gov is the official U.S. registry of clinical trials, maintained by the National Library of Medicine. It lists trials that are currently recruiting, provides eligibility criteria, contact information for the research team, and a plain-language description of the study purpose. For many conditions, searching ClinicalTrials.gov by disease or condition is the most practical way to identify studies for which you might be eligible.

The NIH also maintains resources for patients looking for clinical trial opportunities, as does the National Cancer Institute for cancer-related studies. Your regular healthcare provider can also be an excellent resource for identifying trials relevant to your condition, and should be informed if you decide to enroll in a study, so that your care can be coordinated appropriately.